Delivery Order SPE2DB22D3004-SPE2DB24FPY22
Award Date 4/10/24
Potential Completion Date 4/11/24
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,706.55 firm fixed-price delivery order is for the supply of XTAMPZA ER 27 MG capsules in 100-count bottles. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, for the delivery of XTAMPZA ER 36 MG capsules in 100-count bottles. The award, valued at $1,268.31, is a firm fixed price delivery order with an ultimate completion date of April 11, 2024. AmerisourceBergen Drug Corp is the prime contractor on this award, which does not have a set-aside designation. Additionally,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,066.68 fixed-price delivery order contract is for the supply of XTAMPZA ER 9 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of July 17, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distributor AmerisourceBergen Corporation, provides for the delivery of XTAMPZA ER 27 MG CAPSULE 100S to the Defense Logistics Agency (DLA) Troop Support Medical program, a component of the U.S. Department of Defense. The contract, a firm fixed price delivery order valued at $1,030.78, has an ultimate completion date of April 2, 2024. This order is issued under an indefinite delivery contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,257.87 firm-fixed-price delivery order is for the supply of XTAMPZA ER 27 MG CAPSULE 100S, a pain medication. The contract has an ultimate completion date of September 26, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $10,012.04 firm-fixed-price delivery order is for the supply of XTAMPZA ER CAPS 18MG, a pharmaceutical product. The contract has a period of performance through July 22, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous Indefinite Delivery Contracts (IDCs) by the DLA and other federal...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $4,384.91 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 100 units of the pharmaceutical product XTAMPZA ER 36 MG CAPSULE. This order is being fulfilled under an existing indefinite delivery contract (IDC) issued by DLA to AmerisourceBergen Drug Corp, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,544.57, is for the delivery of XTAMPZA ER 9 MG CAPSULE 100S, a prescription medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 22, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,959.19 firm fixed-price delivery order is for 4566295836 XTAMPZA ER 27 MG CAPSULE 100S, a specialty medication. The contract has an ultimate completion date of November 1, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award SPE2DX15D2215|SPE2DX24F2C8N was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,461.78 firm fixed price delivery order is for the supply of XTAMPZA ER 27 MG CAPSULE 100S, a prescription medication. The award has an ultimate completion date of April 4, 2024 and does not utilize any set-aside...